Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Duloxetine - low dose
DRUG
3 trials
Sponsors
Boehringer Ingelheim
, Orthopaedic Arthroscopy Knee and Shoulder Clinic
, Beni-Suef University
Conditions
Central Sensitisation
Central Sensitization
Healthy
Osteoarthritis of Knee
Peripheral Neuropathy With Type 2 Diabetes
Phase 1
Tolerability and Safety of Duloxetine BID in Healthy Female Subjects
Completed
NCT02232542
Boehringer Ingelheim
Healthy
Start: 2003-06-30
Updated: 2014-09-05
Phase 4
Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty
Completed
NCT06837012
Orthopaedic Arthroscopy Knee and Shoulder Clinic
Central Sensitisation, Central Sensitization, Osteoarthritis of Knee
Start: 2021-01-01
End: 2022-07-31
Updated: 2025-02-20
Unknown Phase
Frequency Rhythmic Electrical Modulated Stimulation Effect in Peripheral Neuropathy Patients Severity of Cases and Qol.
Not yet recruiting
NCT07645482
Beni-Suef University
Peripheral Neuropathy With Type 2 Diabetes
Start: 2026-07-01
End: 2026-08-01
Target: 40
Updated: 2026-07-21